FABRE-KRAMER PARTNERS WITH MISSION PHARMACAL FOR FUTURE COMMERCIAL MANUFACTURE OF NOVEL MECHANISM ANTIDEPRESSANT TRAVIVO™ (GEPIRONE HCL) TABLETS HOUSTON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) of Houston, TX, and Mission Pharmacal Company (Mission) of San Antonio, TX, announced today that they...